DRCT vs REVB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

DRCT

40.3
AI Score
VS
DRCT Wins

REVB

29.6
AI Score

Investment Advisor Scores

DRCT

40score
Recommendation
HOLD

REVB

30score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric DRCT REVB Winner
Forward P/E 5.1125 0.8875 REVB
PEG Ratio 0 0 Tie
Revenue Growth -22.8% 0.0% REVB
Earnings Growth 302.2% 0.0% DRCT
Tradestie Score 40.3/100 29.6/100 DRCT
Profit Margin -74.4% 0.0% REVB
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

DRCT 1M: -52.4% · 3M: -67.0% REVB 1M: +459.6% · 3M: +270.9%

Current Technical Phase

DRCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.4%), weak momentum, RSI 18

RSI (14): 17.9 · Price: $0.91

REVB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (114.4% over 20 days), RSI 67

RSI (14): 67.4 · Price: $4.27

Fundamentals Snapshot

Metric DRCT REVB
Market Cap — —
Forward P/E -0.1 -0.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.3% —
Operating Margin -0.4% 0.0%
EPS -197.09 -99.96
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DRCT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.